News

Dow Jones Today: Stock Futures Slip as Investors Monitor News on Tariffs; Tesla Shares Plunge After Musk Announces New Political Party
Stock futures moved slightly lower on Monday as investors digested the latest developments on the global trade front.
Dow Jones Industrial Average falls as Trump delays tariffs again, issues new threats
Despite waffling on the July 9 trade deadline, the Trump administration is back with fresh tariff threats.
Stock Market Today: Dow Falls About 500 Points as Trump Dials Up Tariff Tensions, Extends Deadline
President Trump's tariffs continue to affect global markets and the economy. Follow for live updates on stocks, bonds and markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq ...
US Stock Markets Live: Dow Jones, Nasdaq, and S&P 500 decline in today's session
Stay with Moneycontrol to get real time updates on US MARKET share price, top gainers, top losers and market insights.
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
I've written this kind of article before, addressing whether it's smart to buy into the dividend-paying stocks in the S&P 500 ...
Dow down 250 points as stocks hit session lows
U.S. stocks touched their lowest levels of the session in recent trading, with the Dow Jones Industrial Average down 250 points. Investors have been awaiting more clarity from the White House ...
Stock futures fall after Trump warns of new 10% tariffs on nations aligning with ‘Anti-American' BRICS stance: Live updates
Wall Street is coming off a holiday-shortened week during which the S&P 500 and Nasdaq Composite posted fresh all-time highs.
Investor's Business Daily on MSN3h
Stock Market Today: Dow Jones Retreats, S&P 500 Falls From A New High; Tesla Tumbles While Detention Facility Names Jump (Live Coverage)
The Dow Jones average and the other major indexes fell on the stock market today. Tesla tumbled while detention center stocks ...
Artelo Biosciences Stock Climbs on Positive Preclinical Efficacy for Depression Drug Candidate
Shares of Artelo Biosciences edged up after the company said preclinical data for its ART12.11 drug candidate showed cognitive benefits over existing antidepressants. The stock rose 63% to $16.35 ...